The price now is noise. Low SOI and really low volume means share price will wonder both up and down until we get news.
Readout from trial that started last September is due in September. If we get an idication of safety and a hint of efficacy then, things could become exciting.
Patients with GBM have short life expectencies due to the agressive way the cancer grows. There is no effective SOC. There is no other CarT treating solid tumour.
Lots of potential here if you have patience.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $11.76K | 2.928M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 4817793 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 18563373 | 21 |
View Market Depth
| Last trade - 14.13pm 26/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |